- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
[作者:Douillard, JY; Siena, S; Cassidy, J; Tabernero, J; Burkes, R; Barugel, M; Humblet, Y; Bodoky, G; Cunningham, D; Jassem, J; Rivera, F; Kocakova, I; Ruff, P; Blasinska-Morawiec, M; Smakal, M; Canon, JL; Rother, M; Oliner, KS; Wolf, M; Gansert, J,期刊:Journal of clinical oncology, 页码:4697-4705 , 文章类型: Article,,卷期:2010年28-31]
- Purpose Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody that improves progression-free survival (PFS), is approved as monotherapy for patients with chemotherapy-refractory meta...
- Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005
[作者:Arico, M; Schrappe, M; Hunger, SP; Carroll, WL; Conter, V; Galimberti, S; Manabe, A; Saha, V; Baruchel, A; Vettenranta, K; Horibe, K; Benoit, Y; Pieters, R; Escherich, G; Silverman, LB; Pui, CH; Valsecchi, MG,期刊:Journal of clinical oncology, 页码:4755-4761 , 文章类型: Article,,卷期:2010年28-31]
- Purpose In a previous analysis of 326 children with Philadelphia chromosome (Ph) -positive acute lymphoblastic leukemia (ALL) treated between 1986 and 1996, hematopoietic stem-cell transplantation from HLA-matched relate...
- Response of Histiocytoses to Imatinib Mesylate: Fire to Ashes
[作者:Janku, F; Amin, HM; Yang, D; Garrido-Laguna, I; Trent, JC; Kurzrock, R,期刊:Journal of clinical oncology, 页码:E633-E636 , 文章类型: Article,,卷期:2010年28-31]
-
- Outcomes of Patients With Esophageal Cancer Staged With [F-18] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection?
[作者:Monjazeb, AM; Riedlinger, G; Aklilu, M; Geisinger, KR; Mishra, G; Isom, S; Clark, P; Levine, EA; Blackstock, AW,期刊:Journal of clinical oncology, 页码:4714-4721 , 文章类型: Article,,卷期:2010年28-31]
- Purpose To determine whether [F-18] fluorodeoxyglucose positron emission tomography (FDG-PET) can delineate patients with esophageal cancer who may not benefit from esophagectomy after chemoradiotherapy. Patients and Met...
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
[作者:Sampson, JH; Heimberger, AB; Archer, GE; Aldape, KD; Friedman, AH; Friedman, HS; Gilbert, MR; Herndon, JE; McLendon, RE; Mitchell, DA; Reardon, DA; Sawaya, R; Schmittling, RJ; Shi, WM; Vredenburgh, JJ; Bigner, DD,期刊:Journal of clinical oncology, 页码:4722-4729 , 文章类型: Article,,卷期:2010年28-31]
- Purpose Immunologic targeting of tumor-specific gene mutations may allow precise eradication of neoplastic cells without toxicity. Epidermal growth factor receptor variant III (EGFRvIII) is a constitutively activated and...
- Spiny Follicular Hyperkeratosis Eruption: A New Cutaneous Adverse Effect of Sorafenib
[作者:Franck, N; Barete, S; Moguelet, P; Blanchet, B; Carlotti, A; Ropert, S; Avril, MF; Frances, C; Billemont, B; Goldwasser, F,期刊:Journal of clinical oncology, 页码:E640-E642 , 文章类型: Letter,,卷期:2010年28-31]
-
|